{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T22:19:00Z","timestamp":1715984340243},"reference-count":0,"publisher":"BMJ","issue":"apr30 3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMJ"],"published-print":{"date-parts":[[2013,4,30]]},"DOI":"10.1136\/bmj.f2810","type":"journal-article","created":{"date-parts":[[2013,4,30]],"date-time":"2013-04-30T15:15:20Z","timestamp":1367334920000},"page":"f2810-f2810","source":"Crossref","is-referenced-by-count":1,"title":["Makers of anticancer drugs are \"profiteering,\" say 100 specialists from around the world"],"prefix":"10.1136","volume":"346","author":[{"given":"J.","family":"Laurance","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2013,4,30]]},"container-title":["BMJ"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmj.f2810","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T06:13:39Z","timestamp":1601100819000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.bmj.com\/lookup\/doi\/10.1136\/bmj.f2810"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,30]]},"references-count":0,"journal-issue":{"issue":"apr30 3","published-online":{"date-parts":[[2013,4,30]]},"published-print":{"date-parts":[[2013,4,30]]}},"URL":"https:\/\/doi.org\/10.1136\/bmj.f2810","relation":{},"ISSN":["1756-1833"],"issn-type":[{"value":"1756-1833","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,30]]}}}